Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Solutia To Sell Pharma Services Business | Contract Pharma

What are you searching for?

Sign in
Breaking News

Solutia To Sell Pharma Services Business

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Solutia, Inc.’s subsidiary, Solutia Europe SA/NV (SESA), has reached a definitive agreement to sell its Pharmaceutical Services business, comprised of CarboGen AG and AMCIS AG. Under the terms of the agreement, Dishman Pharmaceuticals & Chemicals, Ltd. will purchase 100% of the stock of CarboGen and AMCIS, as well as certain other assets used in the Pharmaceutical Services business, for $74.5 million. This transaction is subject to removal of the restrictions related to the sale under SESA’s Euronotes, authorization by the bankruptcy court overseeing Solutia’s reorganization, and government and regulatory approvals, which are expected by August 31, 2006.

CarboGen and AMCIS provide drug development and commercialization services for pharmaceutical and biotechnology companies. The Pharmaceutical Services business has R&D facilities at three sites in Switzerland: Aarau, Bubendorf, and Neuland. All intellectual property, patents and trademarks, customer contracts, as well as employees of the Pharmaceutical Services business are included in the transaction.

Dishman, headquartered in Ahmedabad, India is a globally focused company involved in the manufacture of APIs, API intermediates, quaternary compounds and fine chemicals.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics